544 related articles for article (PubMed ID: 31475007)
1. Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.
Blomberg J; Rizwan M; Böhlin-Wiener A; Elfaitouri A; Julin P; Zachrisson O; Rosén A; Gottfries CG
Front Immunol; 2019; 10():1946. PubMed ID: 31475007
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus, Epstein-Barr virus, and human herpesvirus-6 infections in patients with myalgic еncephalomyelitis/chronic fatigue syndrome.
Shikova E; Reshkova V; Kumanova А; Raleva S; Alexandrova D; Capo N; Murovska M; On Behalf Of The European Network On Me/Cfs Euromene
J Med Virol; 2020 Dec; 92(12):3682-3688. PubMed ID: 32129496
[TBL] [Abstract][Full Text] [Related]
3. Myalgic encephalomyelitis/chronic fatigue syndrome and gulf war illness patients exhibit increased humoral responses to the herpesviruses-encoded dUTPase: Implications in disease pathophysiology.
Halpin P; Williams MV; Klimas NG; Fletcher MA; Barnes Z; Ariza ME
J Med Virol; 2017 Sep; 89(9):1636-1645. PubMed ID: 28303641
[TBL] [Abstract][Full Text] [Related]
4. Serological and virological investigation of the role of the herpesviruses EBV, CMV and HHV-6 in post-infective fatigue syndrome.
Cameron B; Flamand L; Juwana H; Middeldorp J; Naing Z; Rawlinson W; Ablashi D; Lloyd A
J Med Virol; 2010 Oct; 82(10):1684-8. PubMed ID: 20827765
[TBL] [Abstract][Full Text] [Related]
5. Human herpesviruses in chronic fatigue syndrome.
Wallace HL; Natelson B; Gause W; Hay J
Clin Diagn Lab Immunol; 1999 Mar; 6(2):216-23. PubMed ID: 10066657
[TBL] [Abstract][Full Text] [Related]
6. Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients.
Ablashi DV; Eastman HB; Owen CB; Roman MM; Friedman J; Zabriskie JB; Peterson DL; Pearson GR; Whitman JE
J Clin Virol; 2000 May; 16(3):179-91. PubMed ID: 10738137
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of IgM antibodies to human herpesvirus 6 early antigen (p41/38) in patients with chronic fatigue syndrome.
Patnaik M; Komaroff AL; Conley E; Ojo-Amaize EA; Peter JB
J Infect Dis; 1995 Nov; 172(5):1364-7. PubMed ID: 7594679
[TBL] [Abstract][Full Text] [Related]
8. Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis/chronic fatigue syndrome.
Apostolou E; Rizwan M; Moustardas P; Sjögren P; Bertilson BC; Bragée B; Polo O; Rosén A
Front Immunol; 2022; 13():949787. PubMed ID: 36341457
[TBL] [Abstract][Full Text] [Related]
9. Cellular Immune Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
Cliff JM; King EC; Lee JS; Sepúlveda N; Wolf AS; Kingdon C; Bowman E; Dockrell HM; Nacul L; Lacerda E; Riley EM
Front Immunol; 2019; 10():796. PubMed ID: 31057538
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous measurement of antibodies to Epstein-Barr virus, human herpesvirus 6, herpes simplex virus types 1 and 2, and 14 enteroviruses in chronic fatigue syndrome: is there evidence of activation of a nonspecific polyclonal immune response?
Manian FA
Clin Infect Dis; 1994 Sep; 19(3):448-53. PubMed ID: 7811864
[TBL] [Abstract][Full Text] [Related]
11. Antibody responses to Epstein-Barr virus, human herpesvirus 6 and human herpesvirus 7 in patients with chronic fatigue syndrome.
Sairenji T; Yamanishi K; Tachibana Y; Bertoni G; Kurata T
Intervirology; 1995; 38(5):269-73. PubMed ID: 8724857
[TBL] [Abstract][Full Text] [Related]
12. Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome.
Seishima M; Yamanaka S; Fujisawa T; Tohyama M; Hashimoto K
Br J Dermatol; 2006 Aug; 155(2):344-9. PubMed ID: 16882173
[TBL] [Abstract][Full Text] [Related]
13. Salivary DNA Loads for Human Herpesviruses 6 and 7 Are Correlated With Disease Phenotype in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Lee JS; Lacerda EM; Nacul L; Kingdon CC; Norris J; O'Boyle S; Roberts CH; Palla L; Riley EM; Cliff JM
Front Med (Lausanne); 2021; 8():656692. PubMed ID: 34422848
[TBL] [Abstract][Full Text] [Related]
14. The persistent viral infections in the development and severity of myalgic encephalomyelitis/chronic fatigue syndrome.
Rasa-Dzelzkaleja S; Krumina A; Capenko S; Nora-Krukle Z; Gravelsina S; Vilmane A; Ievina L; Shoenfeld Y; Murovska M;
J Transl Med; 2023 Jan; 21(1):33. PubMed ID: 36653846
[TBL] [Abstract][Full Text] [Related]
15. Response to valganciclovir in chronic fatigue syndrome patients with human herpesvirus 6 and Epstein-Barr virus IgG antibody titers.
Watt T; Oberfoell S; Balise R; Lunn MR; Kar AK; Merrihew L; Bhangoo MS; Montoya JG
J Med Virol; 2012 Dec; 84(12):1967-74. PubMed ID: 23080504
[TBL] [Abstract][Full Text] [Related]
16. Commentary: Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.
Ariza ME
Front Immunol; 2020; 11():1400. PubMed ID: 32793195
[No Abstract] [Full Text] [Related]
17. EBV/HHV-6A dUTPases contribute to myalgic encephalomyelitis/chronic fatigue syndrome pathophysiology by enhancing TFH cell differentiation and extrafollicular activities.
Cox BS; Alharshawi K; Mena-Palomo I; Lafuse WP; Ariza ME
JCI Insight; 2022 Jun; 7(11):. PubMed ID: 35482424
[TBL] [Abstract][Full Text] [Related]
18. Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray.
Loebel M; Eckey M; Sotzny F; Hahn E; Bauer S; Grabowski P; Zerweck J; Holenya P; Hanitsch LG; Wittke K; Borchmann P; Rüffer JU; Hiepe F; Ruprecht K; Behrends U; Meindl C; Volk HD; Reimer U; Scheibenbogen C
PLoS One; 2017; 12(6):e0179124. PubMed ID: 28604802
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr Virus dUTPase Induces Neuroinflammatory Mediators: Implications for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Williams PhD MV; Cox B; Lafuse PhD WP; Ariza ME
Clin Ther; 2019 May; 41(5):848-863. PubMed ID: 31040055
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers in the diagnostic algorithm of myalgic encephalomyelitis/chronic fatigue syndrome.
Gravelsina S; Vilmane A; Svirskis S; Rasa-Dzelzkaleja S; Nora-Krukle Z; Vecvagare K; Krumina A; Leineman I; Shoenfeld Y; Murovska M
Front Immunol; 2022; 13():928945. PubMed ID: 36300129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
